Spotlight: Argent BioPharma — Pioneering Cannabinoid Innovation for Refractory Epilepsy
A New Era in Neurological Therapeutics In the ever-evolving world of biotech, few companies embody innovation and focus like Argent BioPharma. A clinical-stage biopharmaceutical company based in Australia, Argent is transforming how central nervous system (CNS) and immune-related disorders are treated. With a foundation in polypharmacology and nanotechnology, it is addressing significant unmet needs—most notably, […]